Kyverna Therapeutics (KYTX) Institutional Ownership $3.72 +0.13 (+3.62%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$3.72 0.00 (0.00%) As of 09/3/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)CurrentInstitutional OwnershipPercentage18.08%Number ofInstitutional Buyers(last 12 months)53TotalInstitutional Inflows(last 12 months)$29.15MNumber ofInstitutional Sellers(last 12 months)14TotalInstitutional Outflows(last 12 months)$8.58M Get KYTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data KYTX Institutional Buying and Selling by Quarter Kyverna Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bridgeway Capital Management LLC62,900$193K0.0%-53.9%0.145% 8/15/2025 Bank of America Corp DE33,756$104K0.0%+94.8%0.078% 8/14/2025 Jane Street Group LLC87,769$269K0.0%N/A0.203% 8/14/2025 The Manufacturers Life Insurance Company 118,297$363K0.0%+206.5%0.274% 8/14/2025 Qube Research & Technologies Ltd14,051$43K0.0%N/A0.033% 8/14/2025 Federated Hermes Inc.44,000$135K0.0%+22.2%0.102% 8/13/2025 Marshall Wace LLP62,057$191K0.0%+152.7%0.144% 8/12/2025 XTX Topco Ltd34,939$107K0.0%N/A0.081% 8/12/2025 JPMorgan Chase & Co.27,855$86K0.0%-29.5%0.064% 8/12/2025 Catalyst Funds Management Pty Ltd12,000$37K0.0%N/A0.028% Get the Latest News and Ratings for KYTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2025 Phoenix Wealth Advisors10,500$32K0.0%N/A0.024% 8/8/2025 Geode Capital Management LLC287,601$883K0.0%-49.0%0.665% 8/1/2025 Y Intercept Hong Kong Ltd42,025$129K0.0%N/A0.097% 7/30/2025 Ethic Inc.17,036$56K0.0%N/A0.039% 7/28/2025 TD Asset Management Inc252,196$774K0.0%+179.5%0.584% 7/25/2025 Vanguard Personalized Indexing Management LLC19,122$59K0.0%+25.2%0.044% 7/1/2025 Kera Capital Partners Inc.421,924$1.30M0.3%+12.2%0.976% 6/27/2025 Goldman Sachs Group Inc.104,460$202K0.0%-7.9%0.242% 5/29/2025 Rhumbline Advisers31,614$61K0.0%+22.0%0.073% 5/16/2025 Goldman Sachs Group Inc.104,460$202K0.0%-7.9%0.242% 5/16/2025 Insight Holdings Group LLC989,054$1.91M0.1%+8.3%2.288% 5/16/2025 AQR Capital Management LLC71,057$137K0.0%N/A0.164% 5/15/2025 Cubist Systematic Strategies LLC68,628$132K0.0%+31.1%0.159% 5/14/2025 Wellington Management Group LLP37,828$73K0.0%-86.2%0.088% 5/12/2025 Nuveen LLC47,508$92K0.0%N/A0.110% 4/30/2025 Peapod Lane Capital LLC396,221$765K0.9%N/A0.917% 4/29/2025 Bank of New York Mellon Corp48,784$94K0.0%+22.2%0.113% 4/8/2025 Rhumbline Advisers31,614$61K0.0%+22.0%0.073% 3/24/2025 Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636% 2/19/2025 Public Employees Retirement System of Ohio33,434$125K0.0%N/A0.077% 2/17/2025 Squarepoint Ops LLC11,488$43K0.0%N/A0.027% 2/17/2025 Two Sigma Advisers LP80,290$300K0.0%+375.1%0.186% 2/17/2025 Two Sigma Investments LP181,654$679K0.0%+47.9%0.421% 2/17/2025 Sphera Funds Management LTD.118,758$444K0.1%-52.2%0.275% 2/17/2025 Millennium Management LLC746,521$2.79M0.0%-40.4%1.729% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,288$53K0.0%+53.7%0.033% 2/17/2025 Integral Health Asset Management LLC350,000$1.31M0.1%+75.0%0.811% 2/17/2025 Jacobs Levy Equity Management Inc.461,959$1.73M0.0%+2,225.0%1.070% 2/17/2025 Corton Capital Inc.12,099$45K0.0%N/A0.028% 2/17/2025 Cubist Systematic Strategies LLC52,361$196K0.0%-24.1%0.121% Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why2/17/2025 Bridgeway Capital Management LLC80,000$299K0.0%N/A0.185% 2/17/2025 Bank of America Corp DE21,788$81K0.0%+41.6%0.050% 2/17/2025 BNP Paribas Financial Markets44,983$168K0.0%+65.4%0.104% 2/17/2025 Ameriprise Financial Inc.190,383$712K0.0%+55.1%0.441% 2/14/2025 Northern Trust Corp195,694$732K0.0%+46.1%0.453% 2/14/2025 Price T Rowe Associates Inc. MD593,688$2.22M0.0%-5.5%1.375% 2/14/2025 Stifel Financial Corp39,342$147K0.0%N/A0.091% 2/14/2025 Gilead Sciences Inc.4,126,119$15.43M1.0%N/A9.558% 2/13/2025 Marshall Wace LLP15,241$57K0.0%-52.7%0.035% 2/13/2025 XTX Topco Ltd43,949$164K0.0%-16.8%0.102% 2/13/2025 Barclays PLC89,586$336K0.0%+27.7%0.208% 2/13/2025 Renaissance Technologies LLC44,700$167K0.0%N/A0.104% 2/13/2025 Wells Fargo & Company MN179,012$670K0.0%+16.4%0.415% 2/12/2025 Geode Capital Management LLC539,682$2.02M0.0%+21.7%1.250% 2/12/2025 Franklin Resources Inc.692,028$2.59M0.0%-26.1%1.603% 2/12/2025 Wellington Management Group LLP274,414$1.03M0.0%+16.7%0.636% 2/12/2025 Norges Bank40,000$150K0.0%N/A0.093% 2/12/2025 JPMorgan Chase & Co.2,166,437$8.10M0.0%-9.3%5.018% 2/11/2025 Corebridge Financial Inc.12,811$48K0.0%+42.3%0.030% 2/6/2025 Charles Schwab Investment Management Inc.169,780$635K0.0%+1.9%0.393% 2/4/2025 Bank of New York Mellon Corp39,933$149K0.0%-7.7%0.093% 1/30/2025 Rhumbline Advisers25,920$97K0.0%+31.1%0.060% 1/24/2025 China Universal Asset Management Co. Ltd.9,154$34K0.0%N/A0.021% 1/15/2025 Kera Capital Partners Inc.376,131$1.41M0.4%N/A0.871% 12/26/2024 JPMorgan Chase & Co.2,387,352$11.67M0.0%+15.8%5.530% 11/27/2024 Franklin Resources Inc.936,961$4.58M0.0%+13.8%2.170% 11/19/2024 Barclays PLC70,167$343K0.0%+21.5%0.163% 11/16/2024 Geode Capital Management LLC443,312$2.17M0.0%+19.0%1.027% 11/15/2024 Barclays PLC70,167$343K0.0%+21.5%0.163% 11/15/2024 XTX Topco Ltd52,792$258K0.0%-36.6%0.122% 11/15/2024 Jane Street Group LLC39,193$192K0.0%+78.3%0.091% 11/15/2024 Wellington Management Group LLP235,123$1.15M0.0%-67.0%0.545% 11/15/2024 Sphera Funds Management LTD.248,651$1.22M0.2%+5.3%0.576% 11/15/2024 State Street Corp326,192$1.60M0.0%+3.2%0.756% 11/15/2024 Point72 Asset Management L.P.34,482$169K0.0%N/A0.080% 11/15/2024 Jacobs Levy Equity Management Inc.19,869$97K0.0%N/A0.046% 11/14/2024 Verition Fund Management LLC44,626$218K0.0%N/A0.103% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC101,900$498K0.0%-11.7%0.236% 11/13/2024 BNP Paribas Financial Markets27,197$133K0.0%+2,166.4%0.063% 11/13/2024 FMR LLC6,692$33K0.0%N/A0.016% 11/12/2024 Charles Schwab Investment Management Inc.166,635$815K0.0%+33.2%0.386% 10/24/2024 Novo Holdings A S1,850,000$9.05M0.4%+5.7%4.291% 10/11/2024 Creative Planning11,028$54K0.0%N/A0.026% 8/26/2024 Teachers Retirement System of The State of Kentucky21,410$161K0.0%+69.7%0.050% 8/20/2024 Novo Holdings A S1,750,000$13.13M0.7%+150.0%4.059% 8/15/2024 The Manufacturers Life Insurance Company37,794$283K0.0%+32.6%0.088% 8/15/2024 Millennium Management LLC923,082$6.92M0.0%+32.8%2.141% 8/15/2024 MBB Public Markets I LLC410,191$3.08M0.1%N/A0.951% 8/15/2024 Deerfield Management Company L.P. Series C1,983,000$14.87M0.2%+35.6%4.599% 8/15/2024 Affinity Asset Advisors LLC200,000$1.50M0.2%N/A0.464% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here8/14/2024 Great Point Partners LLC499,152$3.74M0.7%+232.8%1.158% 8/14/2024 Marshall Wace LLP10,400$78K0.0%-93.3%0.024% 8/13/2024 Skandinaviska Enskilda Banken AB publ26,195$196K0.0%+55.8%0.061% 8/12/2024 XTX Topco Ltd83,286$625K0.1%N/A0.193% 8/12/2024 E Fund Management Co. Ltd.189,432$1.42M0.1%N/A0.439% 8/10/2024 Sofinnova Investments Inc.47,850$359K0.0%+378.5%0.111% 8/8/2024 Federated Hermes Inc.16,000$120K0.0%N/A0.037% 8/3/2024 TD Asset Management Inc90,242$677K0.0%N/A0.209% 8/1/2024 Rhumbline Advisers20,007$150K0.0%N/A0.046% 7/26/2024 Bank of New York Mellon Corp55,790$418K0.0%N/A0.129% (Data available from 1/1/2016 forward) KYTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KYTX shares? During the previous two years, 74 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($78.59M), Jennison Associates LLC ($34.74M), Gilead Sciences Inc. ($15.43M), Janus Henderson Group PLC ($15.04M), Deerfield Management Company L.P. Series C ($14.87M), Avoro Capital Advisors LLC ($11.80M), and Novo Holdings A S ($9.05M).Learn more on Kyverna Therapeutics' institutional investors. What percentage of Kyverna Therapeutics' stock is owned by institutional investors? 18.08% of Kyverna Therapeutics' stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings. Which institutional investors have been buying Kyverna Therapeutics' stock? Of the 72 institutional investors that purchased Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gilead Sciences Inc. ($4.13M), Bain Capital Life Sciences Investors LLC ($3.16M), Jennison Associates LLC ($1.40M), Novo Holdings A S ($1.15M), Price T Rowe Associates Inc. MD ($929.63K), Janus Henderson Group PLC ($606.50K), and Deerfield Management Company L.P. Series C ($520.66K). How much institutional buying is happening at Kyverna Therapeutics? Institutional investors have bought a total of 7,936,801 shares in the last 24 months. This purchase volume represents approximately $29.15M in transactions. Which of Kyverna Therapeutics' major shareholders have been selling company stock? Of the 14 institutional investors that sold Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($714.86K), Millennium Management LLC ($507.04K), Geode Capital Management LLC ($276.37K), Franklin Resources Inc. ($244.93K), JPMorgan Chase & Co. ($232.56K), Sphera Funds Management LTD. ($129.89K), and Bridgeway Capital Management LLC ($73.40K). How much institutional selling is happening at Kyverna Therapeutics? Institutional investors have sold a total of 2,321,335 shares in the last 24 months. This volume of shares sold represents approximately $8.58M in transactions. Related Companies MAZE Major Shareholders RZLT Major Shareholders RLAY Major Shareholders IMTX Major Shareholders MRVI Major Shareholders KROS Major Shareholders TERN Major Shareholders TRML Major Shareholders SIGA Major Shareholders PVLA Major Shareholders This page (NASDAQ:KYTX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyverna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kyverna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
